Warner Chilcott plc has received the United States Food and Drug Administration (FDA) approval for Minastrin 24 FE (norethindrone acetate and ethinyl estradiol capsules and ferrous fumarate capsules) for the prevention of pregnancy. Minastrin 24 FE is manufactured for Warner Chilcott by a third party.

The company does not expect to be in a position to commercially launch Minastrin 24 FE during 2013.

Minastrin 24 FE is indicated for use by females of reproductive age to prevent pregnancy.

Warner Chilcott is a leading specialty pharmaceutical company currently focused on the women's healthcare, gastroenterology, urology and dermatology segments of the branded pharmaceuticals market, primarily in North America.